LGC is pleased to announce that Judy Lewent has joined its Board of Directors as a Non-Executive Director. She will also serve as Chair of the Audit Committee.
Ms. Lewent previously served as a Non-Executive Director and Chair of the Audit & Risk Committee of GlaxoSmithKline and was Chair of the Strategy and Finance Committee of Thermo Fisher until May 2021. She continues to serve as a Non-Executive Director and Audit Committee Chair of Motorola Solutions. Ms. Lewent previously worked at Pfizer and Merck & Co. Inc (MSD in the U.K.), including as Merck’s CFO from 1990 until 2007.
Commenting on the announcement, Tim Robinson, CBE, LGC’s CEO, said “Judy is an experienced UK & US non-employee director and Audit Committee Chair, I am delighted she has chosen to join LGC’s board as we continue to use our Science for a Safer World.”